![Jeanne Freddura](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeanne Freddura
Corporate Officer/Principal bij COMMUNITY REDEVELOPMENT INC.
Actieve functies van Jeanne Freddura
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
COMMUNITY REDEVELOPMENT INC. | Corporate Officer/Principal | 02-02-2022 | - |
Loopbaan van Jeanne Freddura
Eerdere bekende functies van Jeanne Freddura
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Syntimmune, Inc.
![]() Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Comptroller/Controller/Auditor | - | - |
Opleiding van Jeanne Freddura
Cambridge College | Undergraduate Degree |
Harvard University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Corporate Officer/Principal | 1 |
Comptroller/Controller/Auditor | 1 |
Undergraduate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
COMMUNITY REDEVELOPMENT INC. | Finance |
Bedrijven in privébezit | 1 |
---|---|
Syntimmune, Inc.
![]() Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Jeanne Freddura
- Ervaring